The share price of Turning Point Therapeutics, Inc. (TPTX) now
This company is DELISTED
What analysts predict: $
52-week High/Low: $ / $
50/200 Day Moving Average:
$ / $
This figure corresponds to the Average Price over the previous 50/200 days.
For Turning Point Therapeutics stocks, the 50-day moving average is the support level today.
For Turning Point Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in Turning Point Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Turning Point Therapeutics
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Turning Point Therapeutics share be worth in
2023 - 2027?
When should I take profit in Turning Point Therapeutics stock?
When should I record a loss on Turning Point Therapeutics stock?
What are analysts' forecasts for Turning Point Therapeutics stock?
What is the future of Turning Point Therapeutics stock?
We forecast Turning Point Therapeutics stock performance using neural networks based on historical data on Turning Point Therapeutics stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Turning Point Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Turning Point Therapeutics shares. This happens once a day.
Historical and forecast chart of Turning Point Therapeutics stock
The chart below shows the historical price of Turning Point Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Turning Point Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Turning Point Therapeutics, Inc., a clinical stage biopharmaceutical company, designs and develops new small molecule targeted cancer therapies. He is developing a suite of tyrosine kinase inhibitors (TKIs) that targets cancer genetic factors in previously TKI-naive and TKI-treated patients.
Trending Themes in the Healthcare Sector
Turning Point Therapeutics daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 01
79.61
76.22
83.19
9.15
Dec 02
80.80
76.92
82.06
6.68
Dec 03
81.77
78.53
83.93
6.87
Dec 04
82.46
78.55
86.22
9.76
Dec 05
85.92
83.96
89.63
6.75
Dec 06
84.38
82.45
86.25
4.61
Dec 07
85.79
83.58
87.29
4.43
Dec 08
83.53
81.32
86.84
6.78
Dec 09
88.44
86.64
91.68
5.82
Dec 10
87.43
85.39
89.43
4.73
Dec 11
82.87
79.19
85.95
8.54
Dec 12
85.50
83.30
88.12
5.79
Dec 13
90.22
88.27
93.25
5.64
Dec 14
89.84
86.61
92.86
7.22
Dec 15
91.14
88.29
94.04
6.50
Dec 16
91.30
87.25
93.49
7.16
Dec 17
93.33
88.85
96.58
8.70
Dec 18
90.81
88.47
92.50
4.56
Dec 19
89.61
85.63
91.06
6.34
Dec 20
84.77
81.77
87.62
7.15
Dec 21
86.04
81.96
87.49
6.74
Dec 22
86.35
82.42
88.32
7.17
Dec 23
85.01
83.17
88.01
5.83
Dec 24
87.15
84.59
89.66
6.00
Dec 25
91.12
88.06
93.09
5.71
Dec 26
90.08
86.52
91.97
6.31
Dec 27
90.46
86.72
94.80
9.33
Dec 28
88.89
85.37
90.06
5.50
Dec 29
90.22
86.92
93.31
7.35
Dec 30
89.52
88.23
92.90
5.30
Turning Point Therapeutics Daily Price Targets
Turning Point Therapeutics Stock Forecast 12-01-2023.
Forecast target price for 12-01-2023: $79.61. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 8.383%. Pessimistic target level: 76.22 Optimistic target level: 83.19
Turning Point Therapeutics Stock Forecast 12-02-2023.
Forecast target price for 12-02-2023: $80.80. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.262%. Pessimistic target level: 76.92 Optimistic target level: 82.06
Turning Point Therapeutics Stock Forecast 12-03-2023.
Forecast target price for 12-03-2023: $81.77. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.430%. Pessimistic target level: 78.53 Optimistic target level: 83.93
Turning Point Therapeutics Stock Forecast 12-04-2023.
Forecast target price for 12-04-2023: $82.46. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 8.894%. Pessimistic target level: 78.55 Optimistic target level: 86.22
Turning Point Therapeutics Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $85.92. Positive dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 6.327%. Pessimistic target level: 83.96 Optimistic target level: 89.63
Turning Point Therapeutics Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $84.38. Negative dynamics for Turning Point Therapeutics shares will prevail with possible volatility of 4.402%. Pessimistic target level: 82.45 Optimistic target level: 86.25
Turning Point Therapeutics information and performance
Turning Point Therapeutics Address
N/A
Market Capitalization:
N/A $
Market capitalization of the Turning Point Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of TPTX shares in the company outstanding by the market price of one share.
EBITDA:
N/A $
EBITDA of Turning Point Therapeutics is earnings before interest, income tax and depreciation of assets.
PE Ratio:
N/A
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
N/A
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
N/A
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
N/A
Trailing PE:
N/A
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
N/A
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
N/A
Enterprise Value (EV) /Revenue
EV To EBITDA:
N/A
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
N/A
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website